Encephalitis

Encephalitis is an acute inflammation of the brain.

What is Encephalitis?

Encephalitis is a relatively rare condition that causes inflammation of the brain. Initial symptoms usually include high temperature, headache and joint pain but as the infection progresses, more dangerous symptoms may start to develop and include the following...

What Can Aedes Mosquitoes Transmit?

Autoimmune Encephalitis Classification

Autoimmune encephalitis

Autoimmune encephalitis Diagnosis

Autoimmune Encephalitis Pathophysiology

Autoimmune Encephalitis Treatment

What is Anti-NMDA Receptor Encephalitis?

Diagnosis of Anti-NMDA Receptor Encephalitis

Risk Factors for Anti-NMDA Receptor Encephalitis

Treatment and Prognosis of Anti-NMDA Receptor Encephalitis

Latest Encephalitis News and Research

Needle-free vaccine patch can protect people from deadly Zika virus

A simple-to-apply, needle-free vaccine patch is being developed to protect people from the potentially deadly mosquito-borne Zika virus.

30 Nov 2023

Pigeon virus causes fatal neurological disease in young leukemia patient

A case report details a fatal neurologic disease in an immunocompromised toddler caused by pigeon avian paramyxovirus, underscoring the effectiveness of metagenomic testing in diagnosing complex infectious diseases.

19 Nov 2023

Study highlights variable use and rising costs of antivirals in treating pediatric influenza in the U.S.

The Pediatrics study analyzes trends in antiviral usage among U.S. children and adolescents with influenza, revealing significant variations in dispensing rates and costs, and low usage among children under six years, emphasizing the need for improved treatment strategies.

16 Nov 2023

Emerging tick-borne viral threats in eastern europe and the black sea basin

Tick samples from countries in Eastern Europe and the Black Sea region.

16 Nov 2023

Senolytics show promise in combating brain aging and COVID-19 neuropathology

Study reveals that senolytics can reduce aging in human brain organoids and mitigate COVID-19 neuropathology, suggesting their potential as a therapeutic strategy against brain aging and coronavirus-related neurological complications.

15 Nov 2023

Avian flu decimates 5% of Peru's sea lions, sparking conservation alarm

Over 5,000 Peruvian sea lions, approximately 5% of Peru's population, succumbed to a mass mortality event linked to the avian influenza A(H5N1) virus, signaling an urgent need for research and conservation efforts to prevent further declines. The rapid spread of the virus among these colonially breeding mammals highlights potential risks of cross-species transmission and the necessity for heightened monitoring to avert new pandemics.

5 Nov 2023

Researchers pioneer a novel treatment for the most common autoimmune encephalitis

Researchers at DZNE and Charité - Universitätsmedizin Berlin have pioneered a novel treatment for the most common autoimmune encephalitis.

3 Nov 2023

New NIH plan outlines HSV research framework with four strategic priorities

In response to the persistent health challenges of herpes simplex virus 1 (HSV-1) and HSV-2, today the National Institutes of Health released the Strategic Plan for Herpes Simplex Virus Research.

19 Sep 2023

West Nile virus surges to highest incidence since 2012

Researchers discuss the surveillance of West Nile virus and other arboviruses in the United States.

29 Aug 2023

Expert warns of the increasing risks of European holidays

As the UKHSA issues new essential health guidance for travellers going abroad, a leading testing expert warns of the increasing risks of European holidays.

28 Jul 2023

New study quantifies the incidence of neuropsychiatric events in children with flu

While the incidence of influenza-associated neuropsychiatric events in children in the United States is unknown, the controversy over the use of a common antiviral medication typically administered to treat flu in children has sparked concern among parents and medical professionals alike.

24 Jul 2023

The immunogenicity and safety of poxvirus-based Nipah vaccines that can be used in humans and species

Researchers characterized the immunogenicity and safety of poxvirus-based Nipah vaccines that can be used in humans and species.

19 Jul 2023

DFG funds new clinical research unit to study autoimmune-mediated neurological diseases

How do neurological disorders arise that are caused, triggered, or influenced by antibodies? What better possibilities are there for diagnosis – and above all for treatment? These are the questions addressed by the new Clinical Research Unit "BecauseY" headed by Charité – Universitätsmedizin Berlin. Innovative treatment options will especially benefit patients who at first glance are not suspected of having an antibody-mediated neurological disease.

14 Jul 2023

Government seeks views on proposed changes to the Health Protection Notification Regulations 2010

The Health Protection Notification Regulations 2010 (HPNR) help us respond promptly to suspected cases of infectious disease that could have an impact on public health.

13 Jul 2023

Tick season is here: How to avoid ticks

It's tick season now and researchers from the University of Agder in Norway shed light on the myths and facts about these parasites.

7 Jul 2023

Towards Zika preparedness: immunogenicity insights from vaccine research

Study assesses the safety and immunogenicity of an inactivated Zika virus vaccine candidate.

30 Jun 2023

Albumedix and Valneva expand collaboration to include newly approved inactivated COVID-19 vaccine

Albumedix Ltd., a recognized global leader in Recombinant Human Albumin (rHA), specializing in the enablement of advanced therapies and biopharmaceuticals, today announces the expansion of its existing collaboration with Valneva SE, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need.

From Albumedix Ltd. 29 Jun 2023

Brain organoids provide new insights into HSV-1 encephalitis

The herpes simplex virus-1 can sometimes cause a dangerous brain infection. Combining an anti-inflammatory and an antiviral could help in these cases, report scientists with the Rajewsky and Landthaler labs and the Organoid Platform at the Max Delbrück Center in Nature Microbiology.

22 Jun 2023

Mechanistic insights into how the SARS-CoV-2 virus affects the nervous system, alters its function, and causes neuropathology

Study demonstrates that SARS-CoV-2 infection and viral fusogens cause glial and neuronal fusion.

9 Jun 2023

SARS-CoV-2 virus can cause brain cells to fuse: Study

Researchers at The University of Queensland have discovered viruses such as SARS-CoV-2 can cause brain cells to fuse, initiating malfunctions that lead to chronic neurological symptoms.

8 Jun 2023

Encephalitis

Overview

What Can Aedes Mosquitoes Transmit?

Autoimmune Encephalitis Classification

Autoimmune encephalitis